Public Comments
September 13, 2022
FAH Submits Comments on CY 2023 OPPS Proposed Rule
September 6, 2022
FAH Submits Comments on CY 23 Physician Fee Schedule Proposed Rule
July 27, 2022
FAH Urges HHS Secretary to Extend PHE Past October
June 17, 2022
FAH Comments on FY 2023 Proposed Rule for IPPS/LTCH PPS
June 7, 2022
Affordability of Employer Coverage for Family Members of Employees
May 31, 2022
FAH Comments on Inpatient Rehabilitation Facility PPS for Federal FY2023 and Updates to IRF Quality Reporting Program
May 31, 2022
FAH Comments on FY 2023 Inpatient Psychiatric Facilities PPS-Rate Update and Quality Reporting-RFI
May 19, 2022
FAH to CMS: OIG Report Highlights Need For Further Action to End MA Plan Abuses and Protect Patients
May 9, 2022
FAH Urges Simplification of SEC Cybersecurity Proposed Rule
April 25, 2022
FAH Letter “Applauds” DHS Efforts on Public Charge Policy
April 22, 2022
FAH Urges OSHA to Align its COVID-19 Rules with CDC
April 19, 2022
FAH Urges Continuity Along With Targeted Changes to DOJ/FTC Merger Guidelines
April 19, 2022
FAH Response to CMS’ Request for Information on Access to Coverage and Care in Medicaid & CHIP
March 28, 2022
FAH, Other Health Care Organizations Urge HHS to Renew the COVID-19 Public Health Emergency
March 18, 2022
FAH, AHA Oppose Physician-Owned Hospital Expansion Request
March 18, 2022
FAH Urges NAAG to Investigate Travel Nurse Staffing Agencies
March 7, 2022
FAH comments recommend improvements to Medicare Advantage for 2023
February 11, 2022
FAH Comments on Proposed National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease
February 11, 2022
FAH Letter Urges HHS to Extend COVID-19 PHE; Outlines Patient, Caregiver Needs
February 3, 2022
FAH Submit Comments on Organ Transplant Programs
January 27, 2022
FAH Comments on Health Exchange Network Adequacy Requirements
January 4, 2022
FAH Submits Comments on CMS COVID-19 Vaccine Mandate Rule
December 20, 2021
FAH Submits Comments to HHS on Withdrawing or Repealing SUNSET Final Rule
December 6, 2021
FAH Files Comments on Surprise Billing Requirements
December 6, 2021
FAH Comments on FDA Drug Compounding Guidance for Hospitals
October 18, 2021
FAH Submits Comments on Surprise Billing Provider Enforcement Proposed Rule
October 11, 2021
FAH Opposes IRF Review Choice Demo in Comments to CMS
September 17, 2021
FAH Comments on CY 2022 Medicare OPPS Proposed Rule
September 13, 2021
FAH Comment on CY22 PFS
September 9, 2021
FAH Urges CMS to Reconsider TennCare III Demo Approval
September 7, 2021
FAH Comments on Surprise Billing Part One
September 2, 2021
FAH Outlines Needed Improvements & Offers Solutions to Prior Authorization, Other MA Issues
August 24, 2021
FAH Letter to Zients on Visa Exit Interview
August 20, 2021
FAH Comment Letter on OSHA COVID-19 Emergency Temporary Standard
August 5, 2021
FAH Offers Recommendations to Cabinet Secretaries for IDR Process in No Surprises Act
July 29, 2021
FAH Submits Comments On Rules for ACA Health Insurance Markets
July 1, 2021
FAH Letter Expressing Concerning Non-Compete Draft Law
July 1, 2021
FAH letter to DOS on Visa Exit Interview
June 28, 2021
FAH Comments on FY 2022 IPPS Proposed Rule
June 15, 2021
FAH Joins in Support of H.R. 3746, the Accountable Care In Rural America Act
June 15, 2021
FAH Letter to Cabinet Secretaries Outlines Recommendations for No Surprises Act Implementation
June 10, 2021
FAH Calls on UnitedHealthcare to “Immediately and Permanently” Rescind Controversial ER Policy
June 7, 2021
FAH Comments on Proposed Rule for FY 2022 Inpatient Rehabilitation Facility Prospective Payment System
June 7, 2021
FAH Comments on Medicare Proposed Rule for FY 2022 Inpatient Psychiatric Facility PPS
May 10, 2021
PDMP stakeholder letter to HHS and DOJ
May 10, 2021
Health Groups ask HHS to Extend Deadline on Relief Funding, Distribute Remaining Money
May 7, 2021
FAH Joins Coalition Letter in Response to HIPAA Proposed Rule
May 5, 2021
FAH Joins Letter on MSSP Quality Overhaul
April 16, 2021
Letter to CMS re: MCIT and Definition of “Reasonable and Necessary” Delay of Effective Date
April 12, 2021
Letter to HHS re: Extending the NextGen ACO Model
April 7, 2021
Prior Authorization Letter to CMS
March 19, 2021
Letter on OMB Revisions to MSA-Rural Statistical Areas
February 22, 2021
FAH to HHS: Ready to Join Biden Administration Efforts to Protect Americans’ Access to Health Care
February 17, 2021
FAH IRF Review Choice Demo Comments to CMS
February 2, 2021
FAH Comments on DEA Proposed Rule on Partially Filling of Prescriptions
January 26, 2021
FAH Comments on “Most Favored Nation” Model
January 11, 2021
CMS Cost Report Comment Letter
January 4, 2021
CY2021 OPPS
January 4, 2021
FAH Prior Authorization - API Letter
December 31, 2020
FAH Comments to CMS on Additional Policy and Regulatory Revisions in Response to COVID-19
December 23, 2020
FAH Recommends COVID-19 Waivers for Permanent Policy, Expiration and Future Blanket Status
December 22, 2020
FAH Outlines Health Care Priorities to Biden Transition Team
December 22, 2020
FAH Comments on ACA Exchange Proposed Rule for 2022
December 18, 2020
FAH Submits Comment Letter on Information Blocking Rule
December 4, 2020
Comment Letter, SUNSET Proposed Rule
November 30, 2020
FAH Comments on MA Advance Notice
November 22, 2020
FAH Letter to Biden COVID-19 Task Force
November 2, 2020
FAH CMS CLIA PPACA - Additional Policy and Reg Revisions COVID-19
November 2, 2020
FAH Comments MCIT-Coverage Proposed Rule
October 5, 2020
FAH Opposes CMS Proposal Treating Part C Days in Medicare DSH Calculation
October 5, 2020
FAH Comments on CY21 PFS Proposed Rule
October 5, 2020
FAH Submits Comments on CY 2021 OPPS Proposed Rule
September 16, 2020
FAH Comments on HHS Good Guidance Practices Proposed Rule
August 18, 2020
FAH Response to HWW Stakeholder Call
August 10, 2020
FAH Comment Letter on Grandfathered Plans
July 30, 2020
Higher Education Community Pandemic Liability Letter
July 30, 2020
HALO Surprise Billing Letter to Congress
July 29, 2020
Hospital Letter to CMS on Delaying Repayment of MAAPP
July 13, 2020
FAH Telehealth Taskforce Letter
July 10, 2020
FY2021 IPPS Proposed Rule
July 10, 2020
Waiver Letter to CMS
July 10, 2020
GME Advocacy Coalition Sign On
June 30, 2020
Hospital Associations Group Letter Requesting Delay of Transparency Rule
June 23, 2020
FAH Comments to OIG on Information Blocking and CMPs
June 23, 2020
CMS CJR Extension Comments
May 4, 2020
Azar, Engels HRSA COVID-19 Uninsured
April 23, 2020
HALO Accelerated Payments Letter to CMS, HHS
April 10, 2020
FAH Comments FCC COVID-19 Telehealth Program
April 6, 2020
FAH MA Proposed Rule
April 3, 2020
FAH Letter to Azar
April 1, 2020
FEMA Letter
March 31, 2020
Verma Implementation COVID 033120 with NDMS Attachment Final
March 31, 2020
CARES Act and PHSSEF Letter to Secretary Azar.033020
March 18, 2020
FAH COVID-19 1135 Waiver List to CMS
March 18, 2020
COVID-19 1135 Waiver Letter to CMS
March 15, 2020
HALO Letter to U.S. Surgeon General
March 6, 2020
FAH MA Advance Notice
March 2, 2020
Exchange Benefit and Payment Parameters Proposed Rule Comments 3220
January 31, 2020
FAH Comment Letter on MFAR Proposed Rule
January 30, 2020
FAH Comment Letter on Transparency in Coverage
December 27, 2019
FAH Comments on Tennessee Medicaid "Block Grant"
December 20, 2019
FAH MFAR Comment Period Extension Request
December 20, 2019
FAH AKS Proposed Rule Comments
December 20, 2019
FAH Stark Proposed Rule Comments
December 19, 2019
FAH Comments on FDA CDS Draft Guidance
November 20, 2019
FAH Program Integrity RFI
November 7, 2019
FAH Comments on HRSA Rural Grant Programs RFI
November 4, 2019
Program Integrity - Provider Enrollment
October 16, 2019
DEA Joint Comment Letter: Controlled Substances Quotas
September 27, 2019
CY2020 Physician Fee Schedule Proposed Rule Comments
September 27, 2019
FAH CY2020 OPPS Comment Letter
September 16, 2019
FAH Comment Letter on Proposed Radiation Oncology CMMI Model
September 12, 2019
FAH Comment Letter on Medicaid Access Rule
August 29, 2019
FCC Connected Care Pilot Program Proposed Rule
July 2, 2019
Co-Location Draft Guidance
June 24, 2019
IPPS 2020 FAH Comment Letter
June 17, 2019
FY 2020 IPF Proposed Rule Comment Letter
June 17, 2019
FY 2020 IRF PPS Comment Letter
June 17, 2019
TEFCA 2.0 Letter
June 17, 2019
CMS Ligature Risk Interpretive Guidelines
June 3, 2019
ONC Proposed Rule
June 3, 2019
CMS Proposed Rule - FAH Letter
May 30, 2019
FAH DC Geographic Model RFI Comments
March 29, 2019
FAH responds to Hospital Quality Star Rating on Hospital Compare Public Input Request
March 27, 2019
FAH Comment Letter on Grandfathered Group Health Plans RFI
March 25, 2019
FAH Comment Letter VA Veterans Care Agreements
March 1, 2019
FAH Comments on Medicare Advantage Part D Call Letter
February 19, 2019
FAH Comment Letter 2020 Notice of Benefits and Payment Parameters
January 14, 2019
FAH Responds to FDA’s Request for Comments on the Effects of Drug Shortages
January 14, 2019
FAH Comments on Proposed Medicaid Managed Care Rule
December 21, 2018
FAH Comments on New Section 1332 Guidance
December 21, 2018
FAH Comments on MA and Part D Proposed Rule
December 21, 2018
FAH Comments on Health Reimbursement Arrangements Proposed Rule
December 21, 2018
FAH Comments on International Pricing Index Model ANPRM
December 17, 2018
FAH Comments on Drug Transparency Proposed Rule
December 10, 2018
FAH Supports NLRB Proposed Rule on Joint Employer Standard
December 10, 2018
FAH Comments on Proposed Public Charge Rule Change
December 3, 2018
FAH Comments on Changes to Medicare Appeals Process Proposed Rule
November 19, 2018
FAH Submits Comments on Medicare Burden Reduction Proposed Rule
November 16, 2018
FAH Responds to RFI on IMPACT Act
October 30, 2018
FAH Comments on CMS Hospital Harm Quality Measures for Severe Hyperglycemia and Medication-Related B
October 26, 2018
FAH Responds to OIG Anti-Kickback Statute Request for Information
October 17, 2018
FAH Responds to Request for Information on the Electronic Health Record (EHR) Reporting Program
October 16, 2018
FAH Comments on CMS’s proposed changes to the Medicare Shared Savings Program
October 5, 2018
FAH Comments on FCC Telehealth Pilot Program
September 24, 2018
FAH Comments on CY2019 OPPS Proposed Rule
September 10, 2018
FAH Comments on 2019 Physician Fee Schedule Proposed Rule
August 24, 2018
FAH Stark Law RFI Comments
July 16, 2018
Groups Express Concern to CMS Leader Over Suspension of Risk Adjustment Program
July 16, 2018
FAH Comments on HHS Blueprint
June 26, 2018
FAH Comments on the FY 2019 IRF Prospective Payment System Proposed Rule
June 26, 2018
FAH Comments on FY 2019 Inpatient Psychiatric Facilities (IPF) PPS Proposed Rule
June 25, 2018
FAH Submits Comments to CMS on Proposed FY2019 IPPS & LTCH Payment Rule
May 29, 2018
FAH Comment Letter FDA Compounding Guidance
May 29, 2018
FAH Comment Letter CMMI Direct Provider Contracting Model RFI
May 22, 2018
FAH Comment Letter Medicaid Access Proposed Rule
May 3, 2018
IMPACT Act Medication Profile Measures
April 23, 2018
FAH comment letter_STLD proposed rule
March 6, 2018
FAH Comments on Medicare Advantage Call Letter
March 6, 2018
FAH Comments on Association Health Plans
February 27, 2018
FAH Comments on Quality Measure All-Cause Mortality
February 26, 2018
FAH Comments on OIG Safe Harbor Solicitation
February 20, 2018
MSSP Extreme and Uncontrollable Circumstances IFR
February 18, 2018
FAH Comments on ONC’s Draft Trusted Exchange Framework
February 1, 2018
FAH Comments on FCC Rural Health Care Program
January 29, 2018
CJR Extreme and Uncontrollable Circumstances Policy Comments
January 25, 2018
FAH Comments ASPE Choice and Competition RFI with Enclosure
January 16, 2018
FAH Comments on Medicare Advantage Proposed Rule
January 2, 2018
FAH Comments on Extreme and Uncontrollable Circumstance Policy
December 11, 2017
FAH DRAFT 2019 Letter to Issuers Comments
November 27, 2017
FAH Comments on 2019 Notice of Benefit and Payment Parameters Proposed Rule
November 20, 2017
FAH Comments on CMMI RFI
November 17, 2017
FAH Comment on the Patients Over Paperwork Initiative
October 31, 2017
FAH supports Championing Healthy Kids Act
October 24, 2017
Details Matter: Response to Hospital Drug Pricing Report
October 20, 2017
CSR Coalition Statement
October 16, 2017
FAH Comments on the EPM Cancelation Proposed Rule
October 14, 2017
CSR Coalition Letter
September 27, 2017
FAH Comments on Proposed Methodology Changes to the Hospital Star Ratings Program
September 25, 2017
FAH Comments on Proposed 2018 Home Health Rule
September 23, 2017
Health Care Groups Comment on the Graham-Cassidy Proposal
September 19, 2017
Drug Coalition Letter to House on CREATES
September 18, 2017
Health Care Coalition Sends Letter to Congress Asking for Delay in Medicaid DSH Cuts
September 11, 2017
FAH Comments on 2018 Proposed Hospital Outpatient Prospective Payment
September 11, 2017
FAH Comments on 2018 Proposed Physician Fee Schedule Rule
August 28, 2017
FAH Medicaid DSH Proposed Rule Letter
August 18, 2017
FAH Comments on MACRA 2018 Proposal
July 12, 2017
FAH Responds to Request for Information Regarding Stabilizing Health Insurance Markets
June 26, 2017
FAH Comments on IRF PPS Proposed Rule
June 13, 2017
Attachments to FAH Comments on FY 2018 IPPS Proposed Rule
June 13, 2017
FAH Comments on FY 2018 IPPS Proposed Rule
June 2, 2017
FAH Comments to Labor Secretary on Regulatory Relief Issues
May 17, 2017
FAH Shares Regulatory Relief Recommendations with Administration
April 27, 2017
Coalition Issues Joint Statement on CSR Funding
April 25, 2017
FAH Response to Request for Information in the 2018 Rate Announcement and Final Call Letter
April 25, 2017
FAH Comments on CMS Rule Proposing Delay of Cardiac Bundling Rule
March 3, 2017
FAH Comments on 2018 Medicare Advantage Call Letter
January 3, 2017
